Onercept
- Generic Name
- Onercept
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 199685-57-9
- Unique Ingredient Identifier
- 1IEO802L3J
- Indication
Investigated for use/treatment in psoriasis and psoriatic disorders and crohn's disease.
- Associated Conditions
- -
- Associated Therapies
- -
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
- First Posted Date
- 2004-08-26
- Last Posted Date
- 2013-10-22
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 854
- Registration Number
- NCT00090129
- Locations
- 🇺🇸
Academic Dermatology Associates, Albuquerque, New Mexico, United States
🇺🇸Longmont Clinic PC, Longmont, Colorado, United States
🇺🇸Scott D. Glazer, MD, Buffalo Grove, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath